Literature DB >> 11950461

Evidence for a susceptibility locus for panic disorder near the catechol-O-methyltransferase gene on chromosome 22.

Steven P Hamilton1, Susan L Slager, Gary A Heiman, Zemin Deng, Fatemeh Haghighi, Donald F Klein, Susan E Hodge, Myrna M Weissman, Abby J Fyer, James A Knowles.   

Abstract

BACKGROUND: A well-characterized single nucleotide polymorphism (472G/A-Val/Met-SNP8) in the coding sequence of the catechol-O-methyltransferase (COMT) gene leads to a three- to fourfold difference in enzymatic activity and clinical and animal studies suggest a role in anxiety states like panic disorder.
METHODS: Subjects from 70 panic disorder pedigrees, and 83 "triads", were genotyped at seven single nucleotide polymorphisms (SNPs), polymorphic microsatellites in the first intron of COMT and approximately 339kb upstream of COMT (D22S944) and analyzed for genetic association and linkage.
RESULTS: Linkage analysis showed elevated LOD scores for 472G/A (SNP 8), silent exon 3 substitution (186C/T-SNP 5), and the marker D22S944 (2.88, 2.62, and 2.93, respectively), using a variety of diagnostic and genetic models. Association tests were not significant for the SNPs, but were highly significant for D22S944 (p =.0001-.0003). One three-marker haplotype formed from the above three polymorphisms was significantly associated with panic disorder (p =.0001), as was the "global" p value for this combination (p =.005). In addition, numerous haplotypes with combinations of D22S944 and COMT SNPs were found to be significantly associated with panic disorder.
CONCLUSIONS: Our findings provide strong evidence for a susceptibility locus for panic disorder either within the COMT gene or in a nearby region of chromosome 22.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11950461     DOI: 10.1016/s0006-3223(01)01322-1

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  31 in total

1.  Orofacial pain prospective evaluation and risk assessment study--the OPPERA study.

Authors:  William Maixner; Luda Diatchenko; Ronald Dubner; Roger B Fillingim; Joel D Greenspan; Charles Knott; Richard Ohrbach; Bruce Weir; Gary D Slade
Journal:  J Pain       Date:  2011-11       Impact factor: 5.820

Review 2.  Pain, affective symptoms, and cognitive deficits in patients with cerebral dopamine dysfunction.

Authors:  Johanna M Jarcho; Emeran A Mayer; Ziyue Karen Jiang; Natasha A Feier; Edythe D London
Journal:  Pain       Date:  2012-03-03       Impact factor: 6.961

Review 3.  Genetic animal models of anxiety.

Authors:  Deborah A Finn; Mark T Rutledge-Gorman; John C Crabbe
Journal:  Neurogenetics       Date:  2003-03-29       Impact factor: 2.660

4.  Anxiety with panic disorder linked to chromosome 9q in Iceland.

Authors:  Thorgeir E Thorgeirsson; Högni Oskarsson; Natasa Desnica; Jelena Pop Kostic; Jon G Stefansson; Halldor Kolbeinsson; Eirikur Lindal; Nikolai Gagunashvili; Michael L Frigge; Augustine Kong; Kari Stefansson; Jeffrey R Gulcher
Journal:  Am J Hum Genet       Date:  2003-04-04       Impact factor: 11.025

5.  Genome scan for loci predisposing to anxiety disorders using a novel multivariate approach: strong evidence for a chromosome 4 risk locus.

Authors:  Belhassen Kaabi; Joel Gelernter; Scott W Woods; Andrew Goddard; Grier P Page; Robert C Elston
Journal:  Am J Hum Genet       Date:  2006-01-26       Impact factor: 11.025

6.  Catechol-O-methyltransferase gene val158met polymorphism and depressive symptoms during early childhood.

Authors:  Haroon I Sheikh; Katie R Kryski; Heather J Smith; Lea R Dougherty; Daniel N Klein; Sara J Bufferd; Shiva M Singh; Elizabeth P Hayden
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2013-03-08       Impact factor: 3.568

7.  Association analysis of Rgs7 variants with panic disorder.

Authors:  Christa Hohoff; Anna Neumann; Katharina Domschke; Christian Jacob; Wolfgang Maier; Jürgen Fritze; Borwin Bandelow; Petra Krakowitzky; Matthias Rothermundt; Volker Arolt; Jürgen Deckert
Journal:  J Neural Transm (Vienna)       Date:  2008-09-02       Impact factor: 3.575

8.  Catechol-O-methyltransferase (COMT) gene variants: possible association of the Val158Met variant with opiate addiction in Hispanic women.

Authors:  Bronson E Oosterhuis; K Steven LaForge; Dmitri Proudnikov; Ann Ho; David A Nielsen; Robert Gianotti; Sandra Barral; Derek Gordon; Suzanne M Leal; Jurg Ott; Mary Jeanne Kreek
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-09-05       Impact factor: 3.568

9.  Sympathetic activity relates to adenosine A(2A) receptor gene variation in blood-injury phobia.

Authors:  C Hohoff; K Domschke; K Schwarte; G Spellmeyer; C Vögele; G Hetzel; J Deckert; A L Gerlach
Journal:  J Neural Transm (Vienna)       Date:  2008-07-16       Impact factor: 3.575

10.  Associations between the COMT Val/Met polymorphism, early life stress, and personality among healthy adults.

Authors:  Karin F Hoth; Robert H Paul; Leanne M Williams; Carol Dobson-Stone; Elizabeth Todd; Peter R Schofield; John Gunstad; Ronald A Cohen; Evian Gordon
Journal:  Neuropsychiatr Dis Treat       Date:  2006-06       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.